COM:NEXIMMUNE
NexImmune
- Stock
Last Close
0.30
22/11 20:00
Market Cap
3.17M
Beta: -
Volume Today
1.67K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -9.73K - | -9.73K 0% | |||||
average payables | 1.02M - | 1.97M 93.46% | 1.90M 3.22% | 1.71M 10.06% | 669.35M 39,014.17% | ||
average receivables | 40.02K - | 3.21K 91.98% | 37.23K - | 37.23K 0% | |||
book value per share | 1.11 - | 0.82 25.81% | -0.80 197.09% | 4.15 620.64% | 1.34 67.64% | 3.34 149.10% | |
capex per share | -0.10 - | -0.10 0.41% | -0.04 54.62% | -0.12 166.19% | -0.05 55.20% | -0.05 11.01% | |
capex to depreciation | -4.58 - | -2.86 37.69% | -1.40 51.07% | -2.70 93.34% | -1.26 53.28% | -0.05 96.23% | |
capex to operating cash flow | 0.08 - | 0.06 23.92% | 0.03 48.97% | 0.05 56.77% | 0.02 52.24% | 0.00 93.68% | |
capex to revenue | |||||||
cash per share | 1.23 - | 0.78 36.48% | 0.25 67.54% | 4.05 1,492.52% | 1.44 64.48% | 3.05 111.93% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 1.69 - | 0.02 - | 0.01 66.36% | ||||
debt to equity | -1.21 - | 0.03 - | 0.02 38.21% | ||||
dividend yield | |||||||
earnings yield | -0.05 - | -0.06 19.55% | -0.06 1.92% | -0.56 780.00% | 87.91 15,910.15% | -13.88 115.79% | |
enterprise value | 247.04M - | 318.29M 28.84% | 514.79M 61.74% | 62.73M 87.81% | -27.77M 144.27% | -803.82M 2,794.71% | |
enterprise value over ebitda | -18.95 - | -15.56 17.85% | -18.98 21.95% | -1.20 93.69% | 0.44 137.10% | 0.02 94.51% | |
ev to operating cash flow | -22.22 - | -16.39 26.22% | -19.50 18.93% | -1.37 92.97% | 0.54 139.59% | 0.03 95.29% | |
ev to sales | |||||||
free cash flow per share | -1.23 - | -1.60 29.53% | -1.38 13.69% | -2.38 72.86% | -2.18 8.58% | -30.00 1,276.01% | |
free cash flow yield | -0.05 - | -0.06 29.53% | -0.05 13.69% | -0.52 849.77% | -8.97 1,633.55% | -13.51 50.68% | |
graham net net | 0.90 - | 0.54 39.48% | -1.11 304.76% | 3.69 431.46% | 0.99 73.07% | -1.79 280.28% | |
graham number | 5.72 - | 5.39 5.82% | 5.36 0.53% | 15.47 188.77% | 25.41 64.24% | 48.16 89.53% | |
income quality | 0.87 - | 0.94 9.07% | 0.88 6.44% | 0.90 1.74% | 0.82 8.95% | 0.97 18.65% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -16.55 - | -58.82 255.44% | 0.11 100.19% | ||||
interest debt per share | 1.05 - | 0.04 95.74% | -23.93 53,450.50% | 0.07 100.27% | |||
inventory turnover | |||||||
invested capital | -1.21 - | 0.03 - | 0.02 38.21% | ||||
market cap | 247.47M - | 327.42M 32.31% | 500.71M 52.92% | 93.06M 81.41% | 5.85M 93.71% | 2.33B 39,734.35% | |
net current asset value | 9.00M - | 7.93M 11.91% | -18.66M 335.35% | 79.01M 523.35% | 26.61M 66.32% | 316.73M 1,090.28% | |
net debt to ebitda | 0.03 - | 0.45 1,266.32% | -0.52 216.34% | 0.58 211.44% | 0.54 7.08% | 0.10 82.33% | |
net income per share | -1.31 - | -1.57 19.55% | -1.60 1.92% | -2.56 60.16% | 21.37 933.72% | -30.82 244.21% | |
operating cash flow per share | -1.14 - | -1.50 31.98% | -1.34 11.07% | -2.27 69.80% | -2.13 6.19% | -29.95 1,307.56% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.91 - | -1.48 63.07% | -2.80 89.19% | -0.57 79.70% | 11.94 2,200.72% | -3.76 131.52% | |
revenue per share | |||||||
roe | -1.19 - | -1.91 61.15% | 2.01 204.98% | -0.62 130.76% | 15.92 2,676.78% | -9.22 157.89% | |
roic | -1.26 - | -1.94 53.84% | -8.77 351.09% | -0.65 92.63% | 15.11 2,437.28% | -9.21 160.99% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | 1.11 - | 0.82 25.81% | -0.80 197.09% | 4.15 620.64% | 1.34 67.64% | 3.34 149.10% | |
stock based compensation to revenue | |||||||
tangible asset value | 10.81M - | 10.61M 1.84% | -15.75M 248.47% | 83.76M 631.67% | 32.30M 61.44% | 3.51B 10,765.83% | |
tangible book value per share | 1.11 - | 0.82 25.81% | -0.80 197.09% | 4.15 620.64% | 1.34 67.64% | 3.34 149.10% | |
working capital | 9.33M - | 8.01M 14.14% | -18.63M 332.59% | 79.06M 524.30% | 27.04M 65.81% | 316.73M 1,071.54% |
All numbers in USD (except ratios and percentages)